In vivo evaluation of the EZH2 inhibitor (EPZ011989) alone or in combination with standard of care cytotoxic agents against pediatric malignant rhabdoid tumor preclinical models-A report from the Pediatric Preclinical Testing Consortium
| Image |  |
|---|---|
| Description | scientific article published on 22 October 2020 |
| Author/s |
author: Stephen Erickson Raushan T Kurmasheva Malcolm A Smith Peter J. Houghton |
| Publication date | October 22, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |